NASDAQ: LIME
Neutron Holdings, Inc.CIK 0001699963 · SIC 7372 · Prepackaged Software
Mid by assets
Assets $1.2B
as of Oct 11, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
10-Q
Filed Aug 11, 2026
· Period ending Jun 30, 2026
Red flag
Lime posts $295.4M net income; material weakness in controls disclosed
4 material changes detected. Sign up free to read the summary.
8-K
Filed Aug 4, 2026
· Period ending Aug 4, 2026
Summary not yet generated.
Partner
Trade LIME commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Jul 6, 2026
· Period ending Jul 2, 2026
Summary not yet generated.
424B4
Filed Jul 2, 2026
Critical
Lime prices IPO at $25/share, raising $167M for company and $6.9M for selling stockholders
5 material changes detected. Sign up free to read the summary.
S-1/A
Filed Jun 22, 2026
Red flag
Lime's S-1/A sets $25 IPO price, $141.6M net proceeds, but going-concern risk worsens
5 material changes detected. Sign up free to read the summary.
S-1
Filed May 8, 2026
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 11, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(in thousands, except share and per share amounts)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | 304,224 | 246,068 | 474,374 | 375,083 |
| Cost of revenue | 175,173 | 136,970 | 300,732 | 237,100 |
| Gross profit | 129,051 | 109,098 | 173,642 | 137,983 |
| Operating expenses: | ||||
| Selling, general and administrative | 67,260 | 39,921 | 112,265 | 75,835 |
| Operations and support | 17,738 | 13,604 | 31,129 | 25,445 |
| Research and development | 31,243 | 14,031 | 46,470 | 26,583 |
| Total operating expenses | 116,241 | 67,556 | 189,864 | 127,863 |
| Operating profit (loss) | 12,810 | 41,542 | (16,222) | 10,120 |
| Interest expense | (3,961) | (5,155) | (9,120) | (10,278) |
| Other expense, net | (11,903) | (12,530) | (37,142) | (29,612) |
| (Loss) income before income taxes | (3,054) | 23,857 | (62,484) | (29,770) |
| (Benefit from) provision for income taxes | (298,433) | 3,352 | (296,577) | 5,689 |
| Net income (loss) | 295,379 | 20,505 | 234,093 | (35,459) |
| Net income (loss) per share attributable to common stockholders | ||||
| Basic | 26.70 | 2.15 | 22.08 | (3.74) |
| Diluted | 4.73 | 0.71 | 5.47 | (3.74) |
| Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted | ||||
| Basic | 11,062,716 | 9,557,137 | 10,599,919 | 9,486,896 |
| Diluted | 62,881,519 | 31,348,696 | 48,056,431 | 9,486,896 |
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except share and per share amounts)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 278,065 | 339,825 |
| Short-term restricted cash | 55,671 | 69,470 |
| Accounts receivable, net | 27,900 | 8,145 |
| Deposits | 1,285 | 225 |
| Prepaid expenses and other current assets | 113,890 | 69,175 |
| Total current assets | 476,811 | 486,840 |
| Property and equipment, net | 332,499 | 254,517 |
| Long-term restricted cash | 5,457 | 6,006 |
| Operating lease right-of-use assets | 40,029 | 29,952 |
| Deferred tax assets | 303,289 | 8,623 |
| Other long-term assets | 17,649 | 8,349 |
| Total assets | 1,175,734 | 794,287 |
| Liabilities, Convertible Preferred Stock and Stockholders’ Equity (Deficit) | ||
| Current liabilities: | ||
| Accounts payable | 9,304 | 8,211 |
| Accrued liabilities | 106,870 | 82,061 |
| Accrued compensation | 14,565 | 21,245 |
| Accrued taxes | 36,203 | 25,559 |
| Operating lease liabilities, current | 11,508 | 10,783 |
| Contract liabilities | 5,661 | 6,301 |
| Term loan, current | 114,622 | 113,866 |
| 2021 Notes, current | — | 660,324 |
| Total current liabilities | 298,733 | 928,350 |
| 2020 Notes | — | 207,885 |
| Operating lease liabilities, non-current | 30,138 | 20,033 |
| Other long-term liabilities | 50,659 | 45,372 |
| Total liabilities | 379,530 | 1,201,640 |
| Convertible preferred stock, $0.0001 par value, 20,846,055 shares authorized, 6,916,489 shares issued and outstanding as of June 30, 2026 and December 31, 2025, aggregate liquidation preference of $260,970 as of June 30, 2026 | 114,027 | 114,027 |
| Stockholders’ equity (deficit) | ||
| Common stock, $0.0001 par value, 80,357,143 shares authorized, 50,819,969 and 10,847,267 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 5 | 1 |
| Additional paid-in capital | 1,182,730 | 233,705 |
| Accumulated other comprehensive income (loss) | 10,525 | (9,910) |
| Accumulated deficit | (511,083) | (745,176) |
| Total stockholders’ equity (deficit) | 682,177 | (521,380) |
| Total liabilities, convertible preferred stock and stockholders’ equity (deficit) | 1,175,734 | 794,287 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net income (loss) | 234,093 | (35,459) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Depreciation and amortization | 60,357 | 56,854 |
| Stock-based compensation | 40,721 | 6,121 |
| Amortization of debt discount and debt issuance costs | 878 | 873 |
| Non-cash interest expense on convertible notes | 3,416 | 3,400 |
| Unrealized foreign currency (gains) losses, net | (1,474) | (26,823) |
| Deferred income taxes | (294,878) | (1,335) |
| Loss on vehicle asset disposals | 542 | 415 |
| Loss on change in fair value of the 2021 Notes | 25,239 | 57,554 |
| Cumulative loss of instrument-specific credit risk related to settlement of the 2021 Notes | 19,868 | — |
| Other, net | 1,011 | 1,815 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (18,292) | (12,339) |
| Prepaid expenses and other assets | (47,306) | 2,384 |
| Accounts payable | 985 | (1,031) |
| Accrued and other liabilities | 24,131 | 14,223 |
| Net cash provided by operating activities | 49,291 | 66,652 |
| Cash flows from investing activities | ||
| Purchases of vehicle assets | (122,562) | (80,180) |
| Tariff refund for vehicle assets | 535 | — |
| Purchases of non-vehicle assets | (10,589) | (6,355) |
| Net cash used in investing activities | (132,616) | (86,535) |
| Cash flows from financing activities | ||
| Proceeds from exercises of stock options and other common stock issuances | 3,989 | 2,741 |
| Proceeds from exercises of preferred stock warrants | — | 55 |
| Proceeds from exercises of common stock warrants | 391 | — |
| Settlement of promissory notes issued in exchange for the early exercise of stock options | 9,100 | — |
| Deferred offering costs paid | (5,585) | — |
| Net cash provided by financing activities | 7,895 | 2,796 |
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash | (678) | 11,050 |
| Net decrease in cash and cash equivalents, and restricted cash | (76,108) | (6,037) |
| Cash and cash equivalents, and restricted cash, beginning of period | 415,301 | 300,332 |
| Cash and cash equivalents, and restricted cash, end of period | 339,193 | 294,295 |
| Reconciliation of cash, cash equivalents, and restricted cash to the unaudited condensed consolidated balance sheets | ||
| Cash and cash equivalents | 278,065 | 251,421 |
| Restricted cash | 61,128 | 42,874 |
| Total cash, cash equivalents, and restricted cash | 339,193 | 294,295 |
| Supplemental disclosures of cash flow information | ||
| Cash paid for: | ||
| Income taxes, net of refunds | 2,417 | 4,349 |
| Interest | 5,703 | 5,703 |
| Non-cash investing and financing activities: | ||
| Property and equipment financed by accounts payable and accrued expenses | 16,206 | 10,526 |
| Deferred offering costs not yet paid | 3,058 | — |
| Consideration for promissory note settlement in the form of common stock | 890 | — |
| Conversion of 2020 Notes to common stock | 211,423 | — |
| Conversion of 2021 Notes to common stock | 683,174 | — |
Amounts as printed on the EDGAR/iXBRL face — (in thousands, except share and per share amounts); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗